Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.

Janezic S
Threlfell S
Dodson PD
Dowie MJ
Taylor TN
Potgieter D
Parkkinen L
Senior SL
Anwar S
Ryan B
Deltheil T
Kosillo P
Cioroch M
Wagner K
Ansorge O
Bannerman DM
Bolam JP
Magill PJ
Cragg SJ
Wade-Martins R
Scientific Abstract

The pathological end-state of Parkinson disease is well described from postmortem tissue, but there remains a pressing need to define early functional changes to susceptible neurons and circuits. In particular, mechanisms underlying the vulnerability of the dopamine neurons of the substantia nigra pars compacta (SNc) and the importance of protein aggregation in driving the disease process remain to be determined. To better understand the sequence of events occurring in familial and sporadic Parkinson disease, we generated bacterial artificial chromosome transgenic mice (SNCA-OVX) that express wild-type α-synuclein from the complete human SNCA locus at disease-relevant levels and display a transgene expression profile that recapitulates that of endogenous α-synuclein. SNCA-OVX mice display age-dependent loss of nigrostriatal dopamine neurons and motor impairments characteristic of Parkinson disease. This phenotype is preceded by early deficits in dopamine release from terminals in the dorsal, but not ventral, striatum. Such neurotransmission deficits are not seen at either noradrenergic or serotoninergic terminals. Dopamine release deficits are associated with an altered distribution of vesicles in dopaminergic axons in the dorsal striatum. Aged SNCA-OVX mice exhibit reduced firing of SNc dopamine neurons in vivo measured by juxtacellular recording of neurochemically identified neurons. These progressive changes in vulnerable SNc neurons were observed independently of overt protein aggregation, suggesting neurophysiological changes precede, and are not driven by, aggregate formation. This longitudinal phenotyping strategy in SNCA-OVX mice thus provides insights into the region-specific neuronal disturbances preceding and accompanying Parkinson disease.


2013.Proc. Natl. Acad. Sci. U.S.A., 110(42):E4016-25.

More Like This
Weerasinghe G, Duchet B, Cagnan H, Brown P, Bick C, Bogacz R
2019. PLoS Comput. Biol., 15(8):e1006575.
Unit Publication
Tinkhauser G, Pogosyan A, Tan H, Herz DM, Kühn AA, Brown P
2017. Brain, 140(11):2968-2981.
Unit Publication
Duchet B, Weerasinghe G, Cagnan H, Brown P, Bick C, Bogacz R
2020. J Math Neurosci, 10(1):4.
Unit Publication
Sloan M, Alegre-Abarrategui J, Potgieter D, Kaufmann AK, Exley R, Deltheil T, Threlfell S, Connor-Robson N, Brimblecombe KR, Wallings R, Cioroch M, Bannerman DM, Bolam JP, Magill PJ, Cragg SJ, Dodson PD, Wade-Martins R
2016.Hum. Mol. Genet., 25(5):951-63.
Unit Publication